Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-16

Clinical Trial Update: Rivaroxaban vs. Warfarin in CVT Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing rivaroxaban to warfarin for treatment of cerebral vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)
  • Warfarin (warfarin)

Snippet

Sponsor: Damascus University | Conditions: Cerebral Vein Thrombosis | Phase 3 | Status: COMPLETED